XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Adoption of accounting pronouncement $ 1,105,265   $ 124 $ 1,064,601 $ 3,507 $ 37,033  
Balance at beginning of period, (in shares) at Dec. 31, 2017     124,261        
Balance at beginning of period at Dec. 31, 2017 1,105,265   $ 124 1,064,601 3,507 37,033  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 434,288         434,288  
Adoption of accounting pronouncement 1,063,198   $ 119 1,079,188 (16,109) 0  
Other comprehensive income (loss) (19,616)       (19,616)    
Dividends declared (136,824)     (30,365)   (106,459)  
Net issuances of restricted stock (in shares)     666        
Net issuances of restricted stock 0   $ 1 (1)      
Stock-based compensation 44,953     44,953      
Repurchases of common stock, (in shares)     (5,849)        
Repurchases of common stock (364,868)   $ (6)     (364,862)  
Balance at end of period, (in shares) at Dec. 31, 2018     119,078        
Balance at end of period at Dec. 31, 2018 $ 1,063,198   $ 119 1,079,188 (16,109) 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (usd per share) $ 1.12            
Adoption of accounting pronouncement $ 1,063,198   119 1,079,188 (16,109) 0  
Net income 454,433         454,433  
Adoption of accounting pronouncement 1,063,198   $ 115 1,127,487 (19,986) 36,067 $ (558)
Other comprehensive income (loss) (3,877)       (3,877)    
Dividends declared (145,726)         (145,726)  
Net issuances of restricted stock (in shares)     647        
Net issuances of restricted stock 0   $ 1 (1)      
Stock-based compensation 48,300     48,300      
Repurchases of common stock, (in shares)     (4,605)        
Repurchases of common stock (272,645)   $ (5)     (272,640)  
Balance at end of period, (in shares) at Dec. 31, 2019     115,120        
Balance at end of period at Dec. 31, 2019 $ 1,143,683   $ 115 1,127,487 (19,986) 36,067 (558)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (usd per share) $ 1.24            
Adoption of accounting pronouncement $ 1,143,683   115 1,127,487 (19,986) 36,067 (558)
Net income 306,276         306,276  
Adoption of accounting pronouncement 1,143,683 $ (558) $ 113 1,179,972 (4,732) 29,936 $ (558)
Other comprehensive income (loss) 15,254       15,254    
Dividends declared (156,045)         (156,045)  
Net issuances of restricted stock (in shares)     879        
Net issuances of restricted stock 0   $ 1 (1)      
Stock-based compensation 52,486     52,486      
Repurchases of common stock, (in shares)     (2,871)        
Repurchases of common stock (155,807)   $ (3)     (155,804)  
Balance at end of period, (in shares) at Dec. 31, 2020     113,128        
Balance at end of period at Dec. 31, 2020 $ 1,205,289 (558) $ 113 1,179,972 (4,732) 29,936  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (usd per share) $ 1.36            
Adoption of accounting pronouncement $ 1,205,289 $ (558) $ 113 $ 1,179,972 $ (4,732) $ 29,936